Could cause temporary or reversible harm; serious harm is unlikely.
Presence of Foreign Substance: Product complaint was received of metal contaminant observed in one tablet.
| Brand name | LISINOPRIL |
| Generic name | LISINOPRIL |
| Active ingredient(s) | LISINOPRIL |
| Distributed by / for | Lupin Pharmaceuticals Inc. Baltimore, Maryland 21202 |
| NDC | 68180-980-03 |
| Full product label | Lisinopril Tablets USP, 10mg, 1000-count bottles, Rx only, Manufactured for: Lupin Pharmaceuticals Inc. Baltimore, Maryland 21202, NDC 68180-980-03 |
| Recalling firm | Lupin Pharmaceuticals Inc. |
| Distribution | Product was distributed to distributors, mail order pharmacy and supermarkets throughout the United States. |
| Quantity | 11,706 bottles |
| Recall initiated | 2018-08-13 |
| Report date | 2018-08-22 |
| Recall completed | 2019-10-15 |
| Recall number | D-1077-2018 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | Baltimore MD United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗